IN THIS EDITION: Oral VEGF inhibitor, cediranib, extends life in refractory ovarian cancer Screening has halved colorectal cancer mortality in Europe Diabetes associated with increased risk of incidence and mortality from breast and colorectal...
AMSTERDAM—A molecularly-directed approach to treatment decision-making with patients who have metastatic cancers of unknown primary site was being urged at the 2013 European Cancer Congress by researchers from Arizona who have identified biomarkers...
AMSTERDAM—The 2013 European Cancer Congress heard that new treatments could extend survival in patients with advanced and metastatic melanoma greatly beyond what has been the norm. Dr. Dirk Schadendorf MD from Essen University Hospital in Germany...
Audio Journal of Oncology Podcast Postoperative chest node irradiation extends life in low relapse-risk breast cancer Play Episode Pause Episode 1x 00:00 / Subscribe Apple Podcasts Spotify RSS Feed AMSTERDAM—Postoperative radiotherapy to the...
AMSTERDAM—People with diabetes have an increased risk of developing and dying from certain cancers, according to a meta-analysis with two million patients reported at the 2013 European Cancer Congress in Amsterdam. Researchers found a 23% increased...
CHICAGO—Findings from an expanded phase I study in 107 patients with metastatic melanoma suggest that PD-1 inhibition with the novel agent nivolumab could bring extended remissions. Sarah Maxwell heard the latest at the American Society of Clinical...
CHICAGO— Overall survival improved by more than two-thirds in patients with metastatic melanoma randomised to have GM-CSF added to their ipilimumab therapy. A phase II study in 245 previously treated patients — comparing the effect of ipilumumab...
LONDON—Hematopoietic stem cells are not displaced and depleted by malignant cells in patients with acute myeloid leukaemia but merely put to sleep,
LONDON—Hematopoietic stem cells are not displaced and depleted by malignant cells in patients with acute myeloid leukaemia but merely put to sleep, according to research from London published in PNAS Early Edition. Professor John Gribben from Barts...
DC—A new type of immunotherapy has brought responses in children with acute lymphoblastic leukaemia in relapse who had no other options to prevent the progress of this fatal phase of the disease. At the American Association for Cancer Research
PARIS—The fifth in an annual series of multi-sector Worldwide Innovative Networking (WIN) symposia — dedicated to the advancement of personalised medicine — was held here from July 10th to 12th to promote international collaboration between networks...
CHICAGO—A new approach to dealing simultaneously with several of the identified molecular processes taking place in cancer has brought new prospects for extending life in patients with advanced non small-call lung cancer who have already received...